BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.10−0.12 (-2.30%)
Close on Nov 17, 2026Market cap $234.07MP/E –Yield –
BioAge Labs cash
Cash and short-term investments held at the end of each period.
BioAge Labs's cash was $318.75M at Jun 30, 2026. For fiscal 2025 it was $281.10M, down 20.7% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $281.10M | -20.7% |
| FY2024 | Dec 31, 2024 | $354.35M | +1537.2% |
| FY2023 | Dec 31, 2023 | $21.64M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $318.75M | +7.2% |
| Q1 FY2026 | Mar 31, 2026 | $383.19M | +19.6% |
| Q4 FY2025 | Dec 31, 2025 | $281.10M | -20.7% |
| Q3 FY2025 | Sep 30, 2025 | $285.78M | -14.6% |
| Q2 FY2025 | Jun 30, 2025 | $297.30M | +70.9% |
| Q1 FY2025 | Mar 31, 2025 | $320.52M | +1380.9% |
| Q4 FY2024 | Dec 31, 2024 | $354.35M | – |
| Q3 FY2024 | Sep 30, 2024 | $334.47M | – |
| Q1 FY2024 | Mar 31, 2024 | $173.99M | – |
| Q4 FY2023 | Dec 31, 2023 | $21.64M | – |
See a number that looks wrong?